Alzheimer's News Today

Alzheimer's News Today Your source for Alzheimer’s disease news, support, & real stories from the community. Let’s raise Alzheimer’s disease awareness together!🎗️

The FDA has approved a new first-in-class treatment, Auvelity, for the treatment of agitation associated with Alzheimer’...
05/04/2026

The FDA has approved a new first-in-class treatment, Auvelity, for the treatment of agitation associated with Alzheimer’s disease. https://buff.ly/YODBArE

New analysis links reduced brain atrophy with blarcamesine to better cognition and daily functioning in early Alzheimer’...
04/06/2026

New analysis links reduced brain atrophy with blarcamesine to better cognition and daily functioning in early Alzheimer’s. https://buff.ly/mh4yqAf

Researchers are urging more study into whether a surgical procedure called LVA may be repurposed as a potential Alzheime...
03/02/2026

Researchers are urging more study into whether a surgical procedure called LVA may be repurposed as a potential Alzheimer's disease treatment. https://buff.ly/iFkQDWK

The FDA is reviewing an application seeking expanded approval of an under-the-skin injection version of Leqembi (lecanem...
02/02/2026

The FDA is reviewing an application seeking expanded approval of an under-the-skin injection version of Leqembi (lecanemab). https://buff.ly/jbIwhN9

The FDA gave priority review to an application seeking approval of AXS-05 for Alzheimer's-related agitation, with a deci...
01/06/2026

The FDA gave priority review to an application seeking approval of AXS-05 for Alzheimer's-related agitation, with a decision date of April 30. https://buff.ly/O3BueKd

Semaglutide did not slow Alzheimer’s disease in a pair of clinical trials, so its developer says it will halt the planne...
12/02/2025

Semaglutide did not slow Alzheimer’s disease in a pair of clinical trials, so its developer says it will halt the planned extension periods. https://buff.ly/KKfBj3R

Health Canada conditionally approved Leqembi (lecanemab) to treat mild cognitive impairment or dementia due to early Alz...
11/04/2025

Health Canada conditionally approved Leqembi (lecanemab) to treat mild cognitive impairment or dementia due to early Alzheimer’s. https://buff.ly/ElFQkcO

The European Commission has approved Kisunla (donanemab) for eligible adults with early symptomatic Alzheimer's disease....
10/03/2025

The European Commission has approved Kisunla (donanemab) for eligible adults with early symptomatic Alzheimer's disease. https://buff.ly/7ybqA6D

The FDA has approved Leqembi Iqlik, a subcutaneous, autoinjector formulation for maintenance dosing in people with early...
09/08/2025

The FDA has approved Leqembi Iqlik, a subcutaneous, autoinjector formulation for maintenance dosing in people with early Alzheimer's disease https://buff.ly/ZmMy3tH

September is World Alzheimer's Month, and advocates aim to focus on fighting the stigma surrounding dementia. https://bu...
09/05/2025

September is World Alzheimer's Month, and advocates aim to focus on fighting the stigma surrounding dementia. https://buff.ly/lwHiQR2

Address

Dallas, TX

Telephone

+18009361363

Website

Alerts

Be the first to know and let us send you an email when Alzheimer's News Today posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category